ParkerVision Files 8-K: Material Agreement, Equity Sales

Ticker: PRKR · Form: 8-K · Filed: Dec 31, 2024 · CIK: 914139

Parkervision Inc 8-K Filing Summary
FieldDetail
CompanyParkervision Inc (PRKR)
Form Type8-K
Filed DateDec 31, 2024
Risk Levelmedium
Pages3
Reading Time3 min
Key Dollar Amounts$0.01, $0.50, $5,000,000, $300,000
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, equity-sale, 8-k

TL;DR

ParkerVision filed an 8-K on 12/24/24 for a material agreement and equity sales.

AI Summary

On December 24, 2024, ParkerVision, Inc. filed an 8-K report detailing a material definitive agreement. The filing also covers unregistered sales of equity securities and includes financial statements and exhibits. The company is incorporated in Florida and its principal executive offices are located in Jacksonville.

Why It Matters

This 8-K filing indicates significant corporate activity, including a new material agreement and equity transactions, which could impact the company's financial standing and future operations.

Risk Assessment

Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.

Key Numbers

  • 000-22904 — SEC File Number (Identifies the company's filing history with the SEC.)
  • 59-2971472 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

  • PARKERVISION, INC. (company) — Registrant
  • December 24, 2024 (date) — Date of earliest event reported
  • Florida (location) — State of Incorporation
  • Jacksonville (location) — City of Principal Executive Offices
  • 904-732-6100 (phone_number) — Registrant's Telephone Number

FAQ

What is the nature of the material definitive agreement mentioned in the filing?

The filing indicates a material definitive agreement was entered into, but the specific details of the agreement are not provided in the excerpt.

What type of equity securities were sold under the unregistered sales provision?

The filing mentions unregistered sales of equity securities, but the specific type and terms of these securities are not detailed in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on December 24, 2024.

Where are ParkerVision, Inc.'s principal executive offices located?

ParkerVision, Inc.'s principal executive offices are located at 4446-1A Hendricks Avenue, Suite 354, Jacksonville, Florida 32207.

What is ParkerVision, Inc.'s fiscal year end?

ParkerVision, Inc.'s fiscal year ends on December 31.

Filing Stats: 799 words · 3 min read · ~3 pages · Grade level 10.7 · Accepted 2024-12-31 16:08:18

Key Financial Figures

  • $0.01 — ed shares of ParkerVision common stock, $0.01 par value ("Shares") and 1,000,0000 war
  • $0.50 — 00 warrants ("Warrants"), at a price of $0.50 per share. On December 30, 2024, the Co
  • $5,000,000 — ate proceeds from the sale of Shares of $5,000,000 will be used to fund the Company's oper
  • $300,000 — y thereafter, up to a maximum of 6%, or $300,000. The Shares and Warrants were offered

Filing Documents

01. Entry into a Material Definitive Agreement

Item 1.01. Entry into a Material Definitive Agreement. On December 24, 2024 ParkerVision, Inc. (the " Company ") entered into securities purchase agreements (the " Purchase Agreement ") with accredited investors which provides for the sale of an aggregate of 5,958,402 unregistered shares of ParkerVision common stock, $0.01 par value ("Shares") and 1,000,0000 warrants ("Warrants"), at a price of $0.50 per share. On December 30, 2024, the Company entered into a Purchase Agreement with an accredited investor which provides for the sale of 4,041,598 Shares and 1,000,000 Warrants, also at a price of $0.50 per share. The accredited investors are identified on Exhibit 10.4 hereof (the "Investors"). The Warrants are exercisable for a period of five years at an exercise price of $0.50 per share. The Purchase Agreement contains customary representations and warranties of the Investors. The aggregate proceeds from the sale of Shares of $5,000,000 will be used to fund the Company's operations, including litigation-related expenses. The Company also entered into registration rights agreements (the " Registration Rights Agreement ") with the Investors pursuant to which the Company will register the shares of Common Stock and the shares underlying the Warrants. The Company has committed to file the registration statement no later than April 15, 2025, and to cause the registration statement to become effective by May 20, 2025, or, in the event of a full review by the Securities and Exchange Commission, no later than July 14, 2025. The Registration Rights Agreement provides for liquidated damages upon the occurrence of certain events including failure by the Company to file the registration statement or cause it to become effective by the deadlines set forth above. The amount of the liquidated damages is 1.0% of the aggregate subscription amount paid by the Investors upon the occurrence of the event, and monthly thereafter, up to a maximum of 6%, or $300,000. The Shares and War

02. Unregistered Sales of Equity Securities

Item 3.02. Unregistered Sales of Equity Securities. The disclosures included in Item 1.01 are incorporated herein by reference to the extent required.

01 – Financial Statements and Exhibits

Item 9.01 – Financial Statements and Exhibits. (d) Exhibits Exhibit Description 10.1 Form of Securities Purchase Agreement 10.2 Form of Registration Rights Agreement 10.3 Form of Warrant 10.4 Schedule of Investors 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 31, 2024 PARKERVISION, INC. By /s/ Cynthia French Cynthia French Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.